{"id":"https://openalex.org/W2017574928","doi":"https://doi.org/10.1097/00004850-198704000-00008","title":"The Effects of a 50% Reduction of Cis(z)-Flupenthixol Decanoate in Chronic Schizophrenic Patients Maintained on a High Dose Regime","display_name":"The Effects of a 50% Reduction of Cis(z)-Flupenthixol Decanoate in Chronic Schizophrenic Patients Maintained on a High Dose Regime","alternate_titles":[],"publication_year":1987,"publication_date":"1987-04-01","ids":{"openalex":"https://openalex.org/W2017574928","doi":"https://doi.org/10.1097/00004850-198704000-00008","mag":"2017574928","pmid":"https://pubmed.ncbi.nlm.nih.gov/3298419"},"language":"en","primary_location":{"id":"doi:10.1097/00004850-198704000-00008","doi":"https://doi.org/10.1097/00004850-198704000-00008","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004850-198704000-00008","pdf_url":null,"source":{"id":"https://openalex.org/S149156103","display_name":"International Clinical Psychopharmacology","issn_l":"0268-1315","issn":["0268-1315","1473-5857"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Clinical Psychopharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2017574928"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111692839","display_name":"I. B. Cookson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"I B COOKSON","raw_affiliation_strings":["Department of Psychiatry, Sefton General Hospital, Smithdown Road, Liverpool, L13 2HE, England"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Sefton General Hospital, Smithdown Road, Liverpool, L13 2HE, England","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5111692839"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.3096,"has_fulltext":false,"cited_by_count":40,"citation_normalized_percentile":{"value":0.52171241,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"2","issue":"2","first_page":"141","last_page":"149"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12666","display_name":"Historical Psychiatry and Medical Practices","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-schizophrenia","display_name":"chronic schizophrenia","score":0.7350000143051147},{"id":"https://openalex.org/keywords/dose-reduction","display_name":"dose reduction","score":0.7940000295639038},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.5699999928474426},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.8519999980926514},{"id":"https://openalex.org/keywords/plasma-drug-concentration","display_name":"plasma drug concentration","score":0.7820000052452087},{"id":"https://openalex.org/keywords/prolactin","display_name":"prolactin","score":0.7120000123977661},{"id":"https://openalex.org/keywords/depressive-symptoms","display_name":"depressive symptoms","score":0.6859999895095825},{"id":"https://openalex.org/keywords/tardive-dyskinesia","display_name":"tardive dyskinesia","score":0.9340000152587891},{"id":"https://openalex.org/keywords/antipsychotic-side-effects","display_name":"antipsychotic adverse effects","score":0.8999999761581421}],"concepts":[{"id":"https://openalex.org/C2779158372","wikidata":"https://www.wikidata.org/wiki/Q1546328","display_name":"Tardive dyskinesia","level":3,"score":0.8758233189582825},{"id":"https://openalex.org/C162156334","wikidata":"https://www.wikidata.org/wiki/Q473420","display_name":"Dose","level":2,"score":0.7627143263816833},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5570394992828369},{"id":"https://openalex.org/C2780405171","wikidata":"https://www.wikidata.org/wiki/Q629444","display_name":"Dyskinesia","level":4,"score":0.5446715354919434},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.5405309796333313},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4743160903453827},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.38472703099250793},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3298509120941162},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.30323487520217896},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.05834200978279114},{"id":"https://openalex.org/C2779734285","wikidata":"https://www.wikidata.org/wiki/Q11085","display_name":"Parkinson's disease","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002908","descriptor_name":"Chronic Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005475","descriptor_name":"Flupenthixol","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D005475","descriptor_name":"Flupenthixol","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012565","descriptor_name":"Schizophrenic Psychology","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D013892","descriptor_name":"Thioxanthenes","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1097/00004850-198704000-00008","doi":"https://doi.org/10.1097/00004850-198704000-00008","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004850-198704000-00008","pdf_url":null,"source":{"id":"https://openalex.org/S149156103","display_name":"International Clinical Psychopharmacology","issn_l":"0268-1315","issn":["0268-1315","1473-5857"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Clinical Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:3298419","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3298419","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International clinical psychopharmacology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2027093916","https://openalex.org/W2467674452","https://openalex.org/W2028652116","https://openalex.org/W2088879668","https://openalex.org/W2037733792","https://openalex.org/W2001542022","https://openalex.org/W2078511558","https://openalex.org/W2413187931","https://openalex.org/W2460138319","https://openalex.org/W1969383381"],"abstract_inverted_index":{"Eighteen":[0],"chronic":[1],"schizophrenic":[2,58,92,114],"patients":[3,26,55,65,81],"who":[4],"had":[5,56],"shown":[6],"improvement":[7],"from":[8,67],"increased":[9,49],"maintenance":[10],"dosages":[11],"of":[12,24,35,53,78,91,113,124],"cis(z)-flupenthixol":[13,73,97],"decanoate":[14,74],"were":[15,27,117],"entered":[16,82],"into":[17,83],"a":[18,57,87],"double-blind":[19],"study":[20,43,85],"in":[21,64,107],"which":[22,100],"half":[23],"the":[25,40,44,80,84,102],"randomly":[28],"allocated":[29],"to":[30,69],"be":[31],"maintained":[32],"on":[33],"50%":[34],"their":[36],"pre-trial":[37],"dosage.":[38,104],"During":[39],"44":[41],"week":[42],"reduced":[45,66],"dosage":[46],"group":[47],"showed":[48,86],"morbidity":[50],"and":[51,93,96,119],"one-third":[52],"these":[54],"relapse.":[59],"The":[60],"greatest":[61],"deterioration":[62,90],"occurred":[63],"above":[68],"below":[70],"200":[71],"mg":[72],"biweekly.":[75],"A":[76,127],"review":[77],"all":[79],"relationship":[88],"between":[89],"depressive":[94],"features":[95],"plasma":[98],"levels":[99,106],"reflected":[101],"administered":[103],"Prolactin":[105],"general":[108],"did":[109],"not":[110],"reflect":[111],"control":[112],"symptoms.":[115],"Side-effects":[116],"few,":[118],"there":[120],"was":[121],"no":[122],"emergence":[123],"tardive":[125],"dyskinesia.":[126],"multicentre":[128],"trial":[129],"is":[130],"needed":[131],"for":[132],"further":[133],"evaluation.":[134]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2017574928","counts_by_year":[{"year":2024,"cited_by_count":4},{"year":2022,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
